Youths with type 1 diabetes who used an artificial pancreas system had lower incidence of nocturnal hypoglycemia and better control of nocturnal glucose levels than those who used an insulin pump, an Israeli study showed. Researchers found no evidence of severe adverse reactions with the use of the artificial pancreas. The findings appear in the New England Journal of Medicine.
Artificial pancreas improves nocturnal glucose control in children
SmartBrief Job Listings for Health Care
Attest Health Care Advisors
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
Meridian Health Plan